Answers to FAQs from our 8/25/23 webinar on High-Risk Multiple Myeloma
August 31, 2023
View
MMRF Statement on the FDA Approval of Talvey™ (talquetamab-tgvs) for the Treatment of Multiple Myeloma
August 10, 2023
Answers to FAQs from our 7/14/23 webinar on Minimal Residual Disease
July 18, 2023
Updates in Multiple Myeloma from ASCO 2023 for Healthcare Professionals
June 30, 2023
Answers to FAQs from our 6/20/23 webinar on Learn Your Labs
June 28, 2023
The latest myeloma treatment advances from ASCO 2023
June 8, 2023
Myeloma Investment Fund Invests in Nectin Therapeutics to Evaluate Nectin’s Anti-PVR Lead Drug Candidate as a Treatment for Multiple Myeloma
May 16, 2023
Answers to FAQs from our 5/5/23 webinar on Clinical Studies
May 15, 2023
Answers to FAQs from our 4/5/23 webinar on Multiple Myeloma Precursor Conditions
April 14, 2023
Answers to FAQs from our 3/21/23 webinar on BCMA-Targeted Bispecific Antibodies
March 27, 2023
Meet Sid Moss, MMRF 2023 Walk/Run: Southeast Michigan Spirit of Hope Honoree
March 16, 2023
Meet Lester Weinraub, MMRF 2023 Walk/Run: Philadelphia Spirit of Hope Honoree
March 14, 2023
Knowledge is power. Sign up today and we’ll help you stay informed.
sign up
We value your privacy.
